NewsHealthMidena (Sir): "Retinopathy for diabetic patients is like a...

Midena (Sir): “Retinopathy for diabetic patients is like a heart attack”


“Diabetic retinopathy, regardless of the degree of the disease, represents one of the main parameters of cardiovascular risk. The diabetic subject who has retinopathy is as if he had had a heart attack from the point of view of his health risk. Fundamental prevention and periodic checks because the Diabetic patient has perfect eyesight, but overnight suddenly no longer sees why the retinopathy has progressed in the meantime. ”Edoardo Midena, of the Italian Society of the Retina (Sir) and director of the Eye Clinic, underlines this to Adnkronos Salute of the University of Padua, on the sidelines of the 11th national AMD conference entitled “AMD for diabetology: growth, community and participation”, which was held in Rome. colon light: the subject with diabetic retinopathy does not usually complain of losing vision, so the risk is to arrive late to the diagnosis; moreover, in the past it was believed that it was a disease exclusively of the vascular circulation of the retina, but we know that there is an inflammatory component. This must lead the ophthalmologist to carefully analyze the Oct of the eye in order to choose the most appropriate therapy for the individual patient “. Of the nearly 4 million Italians with diabetes, about 1.2 million – or 30% – live with diabetic retinopathy. Of these, 6-7% lose their vision due to the disease. “Retinopathy – says Midena – can have two forms: non-proliferating and proliferating. In both there can be the most dangerous complication for the purposes of vision, which is diabetic macular edema. The proliferating form is still treated with the laser, a technique. which in the United States is considered superior to other therapies. Macular edema which is the cause of visual loss is currently treated with intravitreal injections of two different categories of drugs: the so-called anti-Vegf which require a monthly administration for at least 5 months and then after two months. So in the first year the injections are about 8. In the following years it is evaluated according to the response that has occurred. The second type of drugs are those cortisone which have a slow and progressive release technology. Their effect has an average duration of 4 months and are repeated only if the macular edema reappears. Thanks to these intravitreal drugs we can manage better and keep the disease under control, without too many limitations for our patients “. According to Midena, the typical patient undergoing intravitreal therapies “is the one who is diagnosed with the disease because he regularly undergoes a screening procedure or because he has noticed that his vision has decreased and therefore turns to an ophthalmologist to do the Oct exam, an investigation that specifically studies the macula, the central area of ​​the retina. This examination reveals the presence of liquid, ie edema ”. At that point the patient “begins the treatment process. A treatment that should not be done for life because diabetic retinopathy is a disease that we can cure in the period of time ranging from 1 to 3 years ”, she concludes.

Latest news

Tour de France 2022 live: the Dane Magnus Cort Nielsen taken over by the peloton

Tour de France 2022 live: the Dane Magnus Cort Nielsen taken over by the peloton Le MondeTour de France:...

FIRST INFO: It will get significantly colder in Slovakia. Temperatures will drop by more than 10 degrees –

The turn of June and July brought a wave of extremely hot weather to Slovakia. Records were being...

You might also likeRELATED
Recommended to you